Effects of paclitaxel and nuclear factor NF-кB inhibitor in thyroid cancer tumors in vivo
Saved in:
| Date: | 2014 |
|---|---|
| Main Authors: | V. M. Pushkarov, O. I. Kovzun, V. V. Pushkarov, M. D. Tronko |
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Series: | Reports of the National Academy of Sciences of Ukraine |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000438195 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Inhibitor of the transcription factor NF-кB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo
by: V. V. Pushkarev, et al.
Published: (2015)
by: V. V. Pushkarev, et al.
Published: (2015)
Paclitaxel action on thyroid anaplastic cancer cell line KTC-3 stable to drug
by: V. V. Pushkarov, et al.
Published: (2012)
by: V. V. Pushkarov, et al.
Published: (2012)
Biochemical effects of combined action of γ-irradiation and paclitaxel on anaplastic thyroid cancer cells
by: V. M. Pushkarev, et al.
Published: (2013)
by: V. M. Pushkarev, et al.
Published: (2013)
Proliferating cells nuclear antigen (PCNA) expression in normal tissues, benign and malignant (metastatic and not metastatic) differentiated human thyroid tumors
by: B. B. Huda, et al.
Published: (2015)
by: B. B. Huda, et al.
Published: (2015)
Expression and activity of extracellular signal regulated kinase-1/2 (ERK1/2) in normal tissues and human thyroid tumors
by: B. B. Huda, et al.
Published: (2016)
by: B. B. Huda, et al.
Published: (2016)
The expression and the activation of protein kinase Akt/PKB in normal tissues, benign and highly differentiated malignant human thyroid tumors
by: B. B. Huda, et al.
Published: (2016)
by: B. B. Huda, et al.
Published: (2016)
Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
Multifocal differentiated thyroid cancer
by: B. B. Guda, et al.
Published: (2019)
by: B. B. Guda, et al.
Published: (2019)
Protein kinase Akt activity in human thyroid tumors
by: B. B. Guda, et al.
Published: (2016)
by: B. B. Guda, et al.
Published: (2016)
Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
Radiation induced thyroid cancer: fundamental and applied aspects
by: Tronko, M., et al.
Published: (2010)
by: Tronko, M., et al.
Published: (2010)
Effect of taxanes on the cell proliferation of thyroid papillary carcinoma
by: O. L. Herashchenko, et al.
Published: (2014)
by: O. L. Herashchenko, et al.
Published: (2014)
Effects of low and high concentrations of antitumour drug taxol in anaplastic thyroid cancer cells
by: Pushkarev, V.M., et al.
Published: (2009)
by: Pushkarev, V.M., et al.
Published: (2009)
Norarginine enhances the antitumor activity of inhibitors of polyamines synthesis in vivo
by: S. P. Zalietok, et al.
Published: (2017)
by: S. P. Zalietok, et al.
Published: (2017)
Aprobation of platelet aggregation inhibitor from Echis multisquamatis snake venom in vitro, in vivo and ex vivo
by: M. A. Zhelavskyi, et al.
Published: (2023)
by: M. A. Zhelavskyi, et al.
Published: (2023)
Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
by: V. V. Pushkarov, et al.
Published: (2021)
by: V. V. Pushkarov, et al.
Published: (2021)
Tumor microenvironment and metabolic factors: contribution to gastric cancer
by: Bubnovskaya, L., et al.
Published: (2023)
by: Bubnovskaya, L., et al.
Published: (2023)
Identification of tumor-associated antigens in human thyroid papillar carcinoma
by: Rodnin, N.V., et al.
Published: (2003)
by: Rodnin, N.V., et al.
Published: (2003)
Differential effects of low and high doses of taxol in anaplastic thyroid cancer cells: possible implication of the PIN1 prolyl isomerase
by: Pushkarev, V.M., et al.
Published: (2008)
by: Pushkarev, V.M., et al.
Published: (2008)
The role of endoplasmic reticulum stress and NLRP3-inflammasomes in the development of atherosclerosis
by: V. V. Pushkarov, et al.
Published: (2021)
by: V. V. Pushkarov, et al.
Published: (2021)
L-MYC gene polymorphism and risk of thyroid cancer
by: Yaylim-Eraltan, İ., et al.
Published: (2008)
by: Yaylim-Eraltan, İ., et al.
Published: (2008)
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: D. Y. Tsyhyka, et al.
Published: (2013)
by: D. Y. Tsyhyka, et al.
Published: (2013)
Effect of the complex of C60 fullerene with doxorubicin on tumor cells in vitro and in vivo
by: S. V. Prylutska
Published: (2014)
by: S. V. Prylutska
Published: (2014)
Impact of siRNA transfection on tumor development under experimental pathology of thyroid gland
by: V. M. Zaporozhan, et al.
Published: (2013)
by: V. M. Zaporozhan, et al.
Published: (2013)
Impact of siRNA transfection on tumor development under experimental pathology of thyroid gland
by: Zaporozhan, V.M., et al.
Published: (2013)
by: Zaporozhan, V.M., et al.
Published: (2013)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
Action of doxorubicin delivered to tumor cells in vitroand in vivo by novel nanoscale oligoelectrolytic carrier
by: N. M. Boiko, et al.
Published: (2013)
by: N. M. Boiko, et al.
Published: (2013)
Immunocytochemical characteristics of thyrocytes in radioiodine refractory metastases of papillary thyroid cancer
by: Zelinskaya, A.
Published: (2023)
by: Zelinskaya, A.
Published: (2023)
The possibility of cytological diagnostics in preoperative prognosis of radioiodine resistance of papillary thyroid cancer
by: H. V. Zelinska
Published: (2018)
by: H. V. Zelinska
Published: (2018)
Investigation of proliferative activity of cells of radioiodine resistant thyroid papillary cancer metastases
by: H. V. Zelinska
Published: (2019)
by: H. V. Zelinska
Published: (2019)
MARK activation in human blood mononuclear cells in types 1 and 2 diabetes
by: V. V. Pushkarov, et al.
Published: (2020)
by: V. V. Pushkarov, et al.
Published: (2020)
Cyclin-dependent kinases 4/6 inhibitors in combination with aromatase inhibitors in treatment of metastatic breast cancer (clinical observation)
by: M. V. Sadchykova, et al.
Published: (2020)
by: M. V. Sadchykova, et al.
Published: (2020)
Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
by: Kirkilevsky, S.I., et al.
Published: (2023)
by: Kirkilevsky, S.I., et al.
Published: (2023)
Change in cryolability of cancer stem cells during in vivo culture of Erlich adenocarcinoma
by: A. M. Holtsev, et al.
Published: (2011)
by: A. M. Holtsev, et al.
Published: (2011)
Histopathological characteristics and post-operative follow-up of patients with potentially radiogenic papillary thyroid carcinoma depending on oncocytic changes availability in the tumor cells
by: Bogdanova, T., et al.
Published: (2023)
by: Bogdanova, T., et al.
Published: (2023)
Biochemical aspects of the combined use of taxanes, irradiation and other antineoplastic agents for the treatment of anaplastic thyroid carcinoma
by: V. M. Pushkarev, et al.
Published: (2018)
by: V. M. Pushkarev, et al.
Published: (2018)
Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression
by: N. Semesiuk, et al.
Published: (2013)
by: N. Semesiuk, et al.
Published: (2013)
The redox-state indices of breast adipose tissue is important factor of tumor microenvironment in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2019)
by: A. P. Burlaka, et al.
Published: (2019)
Computer modeling of direct factor Xa inhibitors
by: D. Demenko, et al.
Published: (2018)
by: D. Demenko, et al.
Published: (2018)
Matrix metalloproteinases as tumor stroma microenvironment factors: the role in course of minimal residual disease in gastric cancer
by: I. I. Hanusevych, et al.
Published: (2015)
by: I. I. Hanusevych, et al.
Published: (2015)
Similar Items
-
Inhibitor of the transcription factor NF-кB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo
by: V. V. Pushkarev, et al.
Published: (2015) -
Paclitaxel action on thyroid anaplastic cancer cell line KTC-3 stable to drug
by: V. V. Pushkarov, et al.
Published: (2012) -
Biochemical effects of combined action of γ-irradiation and paclitaxel on anaplastic thyroid cancer cells
by: V. M. Pushkarev, et al.
Published: (2013) -
Proliferating cells nuclear antigen (PCNA) expression in normal tissues, benign and malignant (metastatic and not metastatic) differentiated human thyroid tumors
by: B. B. Huda, et al.
Published: (2015) -
Expression and activity of extracellular signal regulated kinase-1/2 (ERK1/2) in normal tissues and human thyroid tumors
by: B. B. Huda, et al.
Published: (2016)